ABSTRACT
BACKGROUND@#Total knee arthroplasty (TKA) can reduce severe joint pain and improve functional disability in hemophilia. However, the long-term outcomes have rarely been reported in China. Therefore, this study aimed to evaluate the long-term outcomes and complications of TKA in Chinese patients with hemophilic arthropathy.@*METHODS@#We retrospectively reviewed patients with hemophilia who underwent TKA between 2003 and 2020, with at least 10 years of follow-up. The clinical results, patellar scores, patients' overall satisfaction ratings, and radiological findings were evaluated. Revision surgery for implants during the follow-up period was recorded.@*RESULTS@#Twenty-six patients with 36 TKAs were successfully followed up for an average of 12.4 years. Their Hospital for Special Surgery Knee Score improved from an average of 45.8 to 85.9. The average flexion contracture statistically significantly decreased from 18.1° to 4.2°. The range of motion (ROM) improved from 60.6° to 84.8°. All the patients accepted patelloplasty, and the patients' patellar score improved from 7.8 preoperatively to 24.9 at the last follow-up. There was no statistically significant difference in clinical outcomes between the unilateral and bilateral procedures, except for a better ROM at follow-up in the unilateral group. Mild and enduring anterior knee pain was reported in seven knees (19%). The annual bleeding event was 2.7 times/year at the last follow-up. A total of 25 patients with 35 TKAs were satisfied with the procedure (97%). Revision surgery was performed in seven knees, with 10- and 15-year prosthesis survival rates of 85.8% and 75.7%, respectively.@*CONCLUSIONS@#TKA is an effective procedure for patients with end-stage hemophilic arthropathy, which relieves pain, improves knee functions, decreases flexion contracture, and provides a high rate of satisfaction after more than ten years of follow-up.
Subject(s)
Humans , Arthroplasty, Replacement, Knee/methods , Hemophilia A/surgery , Follow-Up Studies , Retrospective Studies , Treatment Outcome , Knee Joint/surgery , Range of Motion, Articular , Arthritis/complications , Pain , Contracture/surgery , Surgeons , Knee ProsthesisABSTRACT
Resumen Introducción: La hemofilia es una deficiencia congénita de un factor de la coagulación, la cual consta en un trastorno recesivo asociado al cromosoma X, generando disminución o ausencia de actividad funcional del factor. Objetivo: Presentar una revisión narrativa de la literatura sobre pacientes hemofílicos, junto con un caso de manejo de un paciente con la condición. Metodología: Paciente de sexo femenino, 18 años, acude al postgrado de Cirugía y Traumatología bucomaxilofacial de la Universidad Andrés Bello de Santiago de Chile, derivada para realizar exodoncia de terceros molares debido al término de su mecánica ortodóntica. Al realizar la anamnesis próxima, la paciente relata padecer hemofilia A leve, y hace 6 meses presentó un 38% de factor VIII. Previo al tratamiento quirúrgico se solicitó un hemograma completo con examen de coagulación para medir el TTPA. Además, se realizó una interconsulta con el hematólogo tratante para evaluación de su patología y recomendaciones para efectuar la misma con la menor cantidad de riesgos intraquirúrgicos y postquirúrgicos, el cual sugirió la administración de factor VIII previo, y posterior al acto quirúrgico. Así mismo, se aplicaron medidas de hemostasia locales para mejor control y un correcto manejo analgésico postquirúrgico. Conclusión: La hemofilia, es un trastorno que requiere un minucioso manejo tanto pre, intra y postoperatorio de parte del odontólogo, donde los exámenes complementarios, comunicación con el hematólogo, procedimiento atraumático y un correcto manejo de la hemostasia, son fundamentales para el éxito del tratamiento.
Abstract Introduction: Hemophilia is a congenital deficiency of a coagulation factor, associated to a recessive pattern located in the X chromosome, which induces a lower or even absent functional activity of that factor. Objective: To provide a narrative review of the literature about haemophiliac patients, as well as a case report of a patient. Methods: Female patient, 18 years old, attended in the postgraduate of Maxillofacial Surgery of the Andrés Bello University to Santiago, Chile, derived to perform extractions of wisdom teeth due to the end of its orthodontic mechanics. At the anamnesis, the patient reports to suffer from mild hemophilia A, and 6 months ago she had 38% VIII factor. Prior to surgical treatment, a complete blood count with a coagulation test was requested to measure TTPA. In addition, an interconsultation was made with the treating hematologist to perform a correct management to assess of her pathology and recommendations to carry out it with the least amount of intrasurgical and post-surgical risks. Suggested the administration of factor of freeze-dried VIII factor before and after surgery. Local hemostasis measures were also applied for better control and proper post-surgical pain management. Conclusion: Hemophilia, requires the dentist to perform a thorough management pre, intra and postoperatory, in which complementary tests, communication with the hematologist, atraumatic procedure and a precise management of hemostasis, are key for the treatment's success.
Subject(s)
Humans , Female , Adolescent , Surgery, Oral/methods , Hemophilia A/surgery , ChileABSTRACT
Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo de personas con hemofilia abordando principalmente tratamiento médico, quirúrgico y rehabilitación.
Subject(s)
Humans , Hemophilia A/surgery , Hemophilia A/rehabilitationABSTRACT
La hemofilia, enfermedad congénita de baja prevalencia en la población general, se clasifica en tipos A y B según su deficiencia sea del factor VIII o IX de la coagulación. Desde hace más de 40 años existen preparados plasmáticos de cada uno de los factores y en la actualidad contamos con derivados recombinantes. Los pacientes que requieren intervenciones quirúrgicas son un reto para los diferentes grupos de manejo, porque el estándar de criterios para definir la respuesta a la terapia no está claro. Se realizó esta revisión ampliada de la literatura con el fin de evaluar cuáles son los criterios de respuesta en las diferentes publicaciones. En las principales bases de datos médicos, se recolectaron y tabularon 61 artículos después de aplicar los criterios de inclusión y exclusión, encontrando que múltiples estudios aplicaban diferentes parámetros para evaluar el sangrado como son los niveles de factor de la coagulación, tromboelastografía, tiempo de generación de trombina, reintervención quirúrgica, duración de la hospitalización y evaluación de dolor, con lo cual concluimos que hay heterogeneidad en los parámetros que aplican los autores en relación con los objetivos principal y secundarios de nuestra revisión...(AU)
Hemophilia is an inherited low prevalence disorder among the general population classified as type A or B according to the deficiency of either coagulation factor VIII or IX. Coagulation factors in plasma prepared have been available for more than forty years, counting with recombinant factor products nowadays. Patients requiring surgical interventions are a challenge for treating physicians for the criteria standards of therapeutic response are not yet clear. This extended literature review was conducted to evaluate the therapeutic response criteria described in different publications. Sixty-one articles were retrieved from the main medical data bases and tabulated after applying the inclusion and exclusion criteria. Findings showed that many studies considered various parameters to monitor bleeding, such as, levels of coagulation factor, thromboelastography, thrombin generation time, surgical reintervention, length of hospital stay and level of pain. Thus, we conclude there is heterogeneity in the parameters authors apply regarding the primary and secondary objectives of our review...
Subject(s)
Hemophilia A , Hemophilia B , Hemophilia A/surgery , Hemophilia A/therapyABSTRACT
The incidence of post-extraction bleeding and the amount of replacement therapy needed to control bleeding in 24 hemophilic children following the local use of tranexamic acid mouthwash have been investigated. The results of the study showed that 91.6% of patients who used tranexamic acid mouthwash as a supplement to systemic therapy, did not develop post-extraction bleeding; while in 25% of the control patients who received only systemic tranexamic acid, postoperative bleeding was not observed
Subject(s)
Humans , Hemophilia A/surgery , Antifibrinolytic Agents/pharmacology , Tranexamic Acid/pharmacology , Child , ToothABSTRACT
En Pediatría al día vol.10, n§1 se dio a conocer la primera parte de este artículo en el que se abordó la evaluación global del paciente, los tipos de anemia y las anormalidades de los leucocitos, de interés para el cirujano. En esta segunda parte el Dr. Pesse comenta el rol de la hemostasis en el paciente quirúrgico y los criterios básicos en la terapia transfusional perioperatoria
Subject(s)
Infant, Newborn , Infant , Child, Preschool , Child , Hemostasis/physiology , Blood Transfusion/methods , Blood Loss, Surgical , Clinical Laboratory Techniques , Hemophilia A/surgery , Postoperative Period , Preoperative Care , Thrombocytopenia/diagnosis , Thrombocytopenia/etiology , Thrombocytopenia/surgeryABSTRACT
Se presenta el caso de un hombre de 32 anos con historia de hemofilia clasica severa quien presento una fractura subcapital del femur derecho secundario a una crisis epileptica. Se describe el tratamiento pre y pos-quirurgico a base de crioprecipitado, haciendo enfasis en el bajo requerimiento de este componente sanguineo y en su aplicabilidad en nuestro medio. Hasta el presente es el primer caso de este tipo de cirugia, publicado en la literatura medica colombiana